U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839650) titled 'Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training in Al... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muval... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839403) titled 'MOVE-HIP: Ceramic Hip Resurfacing Versus Total Hip Arthroplasty Using Activity Monitoring'... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muval... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'GC-LTFU-001: Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells'. The f... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Sa... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Interventional Study of PF-08634404 in Combination with Chemotherapy in Participants wi... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Effica... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839533) titled 'Acupuncture as an Adjunct Treatment for Lateral Epicondylitis' on Sept. 19. Brief Summary... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy ... Read More